strongyloid
nematod
affect
million
peopl
worldwid
report
great
ape
speci
old
world
common
speci
affect
great
ape
strongyloid
stercorali
strongyloid
infect
anim
human
asymptomat
shedder
howev
immunocompromis
individu
like
affect
clinic
diseas
develop
fulmin
fatal
parasit
surviv
month
environ
increas
skin
contact
infect
soil
substrat
risk
factor
transmammari
transmiss
strongyloid
spp
document
dog
sheep
rat
pig
singl
human
complex
life
cycl
parasit
publish
detail
elsewher
migrat
strongyloid
larva
respiratori
system
gastrointestin
tract
caus
clinic
mani
fatal
human
case
involv
hyperinfect
state
acceler
autoinfect
character
increas
larval
migrat
larval
load
gastrointestin
pulmonari
symptom
vari
greatli
depend
parasit
load
host
health
includ
sign
lethargi
specif
sign
like
cough
dyspnea
diarrhea
constip
inappet
abdomin
great
ape
orangutan
year
old
appear
suscept
sever
clinic
diseas
like
due
sever
fatal
report
literatur
well
young
chimpanze
report
describ
effect
erad
strategi
asymptomat
adult
util
prevent
deworm
first
publish
report
describ
antemortem
diagnosi
treatment
dissemin
strongyloidiasi
clinic
affect
great
ape
infant
may
femal
sumatran
orangutan
pongo
abelii
present
acut
lethargi
period
dri
cough
anim
hous
zoolog
institut
famili
group
consist
adult
anim
health
depart
must
provid
veterinari
care
anim
orangutan
famili
group
provid
indoor
outdoor
hous
outdoor
yard
consist
natur
substrat
indoor
hous
compos
artifici
tree
concret
rockwork
hammock
platform
climb
variou
enrich
mental
stimul
complianc
usda
requir
orangutan
also
provid
wood
wool
hay
blanket
brows
orangutan
fed
balanc
diet
overseen
nutritionist
provid
variabl
way
includ
train
session
enrich
devic
via
etc
oral
amoxicillin
mgkg
mg
bid
mgml
suspens
virbac
ah
inc
fort
worth
tx
usa
acetaminophen
mgkg
bid
mgml
suspens
mcneil
consum
healthcar
fort
washington
pa
usa
given
day
present
initi
improv
document
second
day
infant
less
activ
slow
nurs
cough
longer
note
depth
respir
increas
sternal
recumb
day
orangutan
show
poor
medic
complianc
seen
nurs
regularli
increas
respiratori
effort
sleep
respiratori
rate
breathsmin
anim
refus
oral
medic
antimicrobi
switch
oral
amoxicillin
intramuscular
azithromycin
mgkg
sid
mgml
inject
apotox
corp
weston
fl
usa
opportunist
urinalysi
unremark
usg
ph
yellowclear
moder
debri
rare
red
blood
cell
day
infant
induc
isofluran
via
facemask
isothesia
henri
schein
anim
health
dublin
oh
usa
intub
mm
endotrach
tube
ett
maintain
isofluran
facilit
complet
evalu
obtain
diagnost
test
administ
treatment
intraven
azithromycin
mgkg
ceftazidim
mgkg
mlml
inject
hospira
worldwid
inc
lake
forest
il
usa
subcutan
meloxicam
mgkg
mgml
inject
norbrook
laboratori
limit
counti
northern
ireland
administ
procedur
thorac
auscult
reveal
elev
respiratori
rate
breathsmin
harsh
lung
sound
intermitt
crackl
left
side
chest
heard
prior
intub
institut
intermitt
posit
pressur
ventil
orangutan
hyperventil
throughout
anesthesia
end
tidal
carbon
dioxid
mm
hg
oxygen
satur
within
clinic
accept
limit
puls
oximet
bilater
dri
nasal
discharg
present
abdomen
bloat
fece
collect
via
rectal
swab
yellow
unform
gingiva
discolor
light
yellow
predominantli
near
tooth
erupt
site
whole
bodi
radiograph
show
mild
hepatomegali
intestin
loop
suggest
ileu
patchi
interstiti
infiltr
air
bronchogram
left
lung
field
abdomin
ultrasound
reveal
hyperecho
periport
area
liver
slight
gall
bladder
wall
thicken
present
nasal
swab
cytolog
show
squamou
epitheli
cell
bacilli
megabacteria
white
blood
cell
right
tonsil
swab
cultur
reveal
growth
pathogen
nasopharyng
swab
submit
respiratori
pathogen
multiplex
pcr
detect
follow
pathogen
bordetta
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
adenoviru
coronaviru
influenza
subtyp
b
metapneumoviru
parainfluenza
barn
jewish
hospit
st
loui
mo
usa
blood
collect
complet
blood
cell
count
serum
chemistri
advanc
veterinari
laboratori
st
loui
mo
usa
blood
glucos
aviva
plu
roch
indianapoli
plasma
chemistri
abaxi
inc
union
citi
ca
usa
blood
ga
analysi
istat
istat
abbott
point
care
inc
abbott
park
il
usa
test
show
normoglycemia
glucos
mgdl
hyponatremia
hypochloremia
hyperkalemia
elev
total
bilirubin
consist
icter
oral
mucou
membran
tabl
find
confirm
laboratori
test
sampl
addit
mild
elev
gamma
glutamyl
transferas
ggt
increas
direct
fraction
compar
indirect
fraction
bilirubin
note
tabl
complet
blood
cell
count
show
leukocytosi
equal
neutrophil
lymphocyt
distribut
mild
anemia
tabl
cytolog
mucou
hemorrhag
ett
show
white
blood
cell
transit
cell
squamou
epitheli
cell
cultur
grew
staphylococcu
aureu
sensit
test
antibiot
includ
azithromycin
except
ampicillin
clindamycin
pathogen
isol
fecal
cultur
fecal
direct
examin
neg
parasit
modifi
stain
show
bacilli
megabacteria
present
fecal
gram
stain
modifi
stain
reveal
larval
parasit
morpholog
consist
strongyloid
speci
figur
anim
diagnos
pneumonia
icteru
due
dissemin
strongyloid
infect
prescrib
oral
ivermectin
mgkg
mgml
suspens
norbrook
laboratori
limit
oral
azithromycin
mgkg
po
sid
day
mgml
suspens
greenston
llc
peapack
nj
usa
meloxicam
mgkg
po
sid
day
mgml
suspens
norbrook
laboratori
limit
institut
day
anesthesia
orangutan
nurs
well
take
medic
next
day
infant
less
bloat
appear
brighter
activ
ten
day
behavior
normal
gingiv
icteru
resolv
recheck
fecal
posit
nematod
larva
via
baermann
concentr
techniqu
ivermectin
mgkg
po
meloxicam
mgkg
po
prescrib
weekli
treatment
adult
orangutan
neg
routin
baermann
fecal
screen
orangutan
start
monthli
ivermectin
mgkg
po
prevent
orangutan
bed
protocol
chang
elimin
hay
reus
clean
wood
wool
individu
recurr
clinic
symptom
parasit
fecal
examin
year
sinc
diagnosi
treatment
initi
monthli
ivermectin
prophylaxi
bronchial
lavag
perform
diagnosi
case
base
compat
clinic
symptom
thorac
radiograph
hepat
ultrasound
exclus
caus
pneumonia
respons
treatment
find
strongyloid
suspect
anim
contract
parasit
contamin
substrat
although
transmammari
transmiss
rule
singl
fecal
sampl
sensit
diagnosi
use
baermann
acet
concentr
techniqu
improv
altern
serial
fecal
examin
sever
week
may
necessari
detect
strongyloid
speciat
pursu
case
diagnosi
base
previous
describ
distinguish
morpholog
treatment
option
strongyloid
infect
includ
azol
drug
oral
ivermectin
becom
treatment
choic
shown
better
rate
larval
clearanc
fewer
neg
side
mortal
rate
dissemin
strongyloidiasi
human
remain
high
prognosi
especi
poor
patient
requir
oxygen
support
mechan
treatment
case
like
success
due
intervent
prior
sever
respiratori
compromis
first
publish
report
describ
antemortem
diagnosi
treatment
dissemin
strongyloidiasi
use
oral
ivermectin
infant
orangutan
report
emphas
valu
prophylact
anthelmint
use
erad
strongyloid
speci
especi
group
pregnant
lactat
infant
interestingli
adult
anim
breed
group
neg
routin
fecal
screen
year
lead
case
howev
baermann
techniqu
routin
use
time
recommend
control
measur
includ
maintain
exemplari
exhibit
hygien
util
baermann
fecal
screen
techniqu
identifi
treat
subclin
infect
orangutan
